Sarah Hollingsworth “Holly” Lisanby, MD, DLFAPA
Founding dean
Dr. Lisanby is the founding dean of the ASU John Shufeldt School of Medicine and Medical Engineering. With prior senior leadership roles at Duke University, Columbia University and the National Institutes of Health, Dr. Lisanby brings deep expertise in psychiatry, research strategy and engineering innovation. Her research focuses on the convergence of engineering and medicine. An accomplished clinical translational scientist, Dr. Lisanby is internationally known for her pioneering research leading to the FDA approval of novel devices for the treatment of depression. In her most recent roles at NIH, Dr. Lisanby was responsible for a portfolio of approximately $400 million to support mental health research and she designed and led teams within the NIH BRAIN Initiative on the development of novel devices and AI approaches to transform brain health. Dr. Lisanby founded and directed both the National Institute of Mental Health (NIMH) Noninvasive Neuromodulation Unit and served as the director of the NIMH Division of Translational. Prior to NIH, Dr. Lisanby was the JP Gibbons Endowed Professor and Chair of the Department of Psychiatry and Behavioral Sciences at Duke, where she is now Professor Emeritus. Dr. Lisanby has received numerous national and international awards, including the Distinguished Investigator Award from the Brain and Behavior Research Foundation, the Max Hamilton Memorial Prize of the Collegium Internationale Neuro-Psychopharmacologicum (CINP), the Gerald R. Klerman Award from the Depression and Bipolar Support Alliance and the Eva King Killam Research Award from the American College of Neuropsychopharmacology (ACNP). Dr. Lisanby is an elected member of the American Association of Physicians, a Fellow of the ACNP and a Distinguished Life Fellow of the American Psychiatric Association (DLFAPA). Dr. Lisanby serves on the FDA Neurological Devices Advisory Panel and has held key senior leadership positions in international professional organizations including serving as President of the International Society for ECT and Neurostimulation.











